This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.
6 March 2024
ESKEN LIMITED
("Esken" or the "Company")
Update on the future of the Company
Further to the announcement issued on 19 February 2024, Esken, the aviation group, announces that the board of the Company has negotiated and agreed the launch of a restructuring plan (pursuant to part 26A of the Companies Act 2006) with Cyrus Capital Partners ("Cyrus") (the majority holder of the exchangeable bond of
As a result, the Company has agreed to accede to that recapitalisation proposal in relation to LSA. This will therefore proceed on a consensual basis, rather than through a contested court process, which could be potentially destructive for all stakeholders. The terms of the recapitalisation proposal for LSA involves a conversion of the convertible loan of
The terms of the proposed restructuring plan for Esken, which will require a court process and is expected to complete after the LSA recapitalisation process, would involve amongst other things an equitisation of the exchangeable bond, and certain other creditors within the Group, and a delisting of the shares on the London Stock Exchange. The expectation is that any return for shareholders at the end of the process is likely to be negligible. Cyrus will provide liquidity to the Esken group to meet its working capital needs during this process and to allow an orderly wind down of the remaining group.
While the board had previously announced its intention to (i) dispose of certain non-core assets for a consideration of
The court process for the Esken restructuring plan is likely to take several months to conclude but, in the meantime, the future funding of LSA is secure and the board will progress the orderly wind down of the remaining group. Once the documents for the restructuring plan are finalised a further update will be provided when the process and timings will be set out fully.
Enquiries:
Esken Limited c/o Teneo
Teneo
Olivia Peters
+44 7902 771008
esken@teneo.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.